(VIANEWS) – The NASDAQ opens in less than one hour and Castle Biosciences‘s pre-market value is already 22.75% up.
The last session, NASDAQ Composite ended with Castle Biosciences (CSTL) dropping 0.29% to $62.73. NASDAQ Composite dropped 0.82% to $15,090.20, following the last session’s downward trend on what was a somewhat negative trend exchanging session.
Today’s last reported volume for Castle Biosciences is 90407, 42.65% below its average volume of 157664.
Castle Biosciences’s last close was $62.91, 41.58% below its 52-week high of $107.69.
Castle Biosciences’s Sales
Castle Biosciences’s sales growth is 53.2% for the current quarter and 39.2% for the next. The company’s growth estimates for the ongoing quarter and the next is a negative 73.9% and a negative 69.6%, respectively.
Castle Biosciences’s Revenue
Year-on-year quarterly revenue growth grew by 31%, now sitting on 68.04M for the twelve trailing months.
Castle Biosciences’s Stock Yearly Top and Bottom Value
Castle Biosciences’s stock is valued at $62.73 at 09:18 EST, way under its 52-week high of $107.69 and way higher than its 52-week low of $43.37.
Castle Biosciences’s Moving Average
Castle Biosciences’s value is below its 50-day moving average of $69.27 and below its 200-day moving average of $67.71.
Castle Biosciences’s last day, last week, and last month’s current volatility was 3.29%, 3.79%, and 4.06%, respectively.
Castle Biosciences’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 5.75% (day), 5.99% (last week), and 5.22% (last month), respectively.
More news about Castle Biosciences (CSTL).